[Problematic aspects of placebo-controlled double-blind studies with highly effective drugs such as etretinate].
Highly potent drugs should be studied by means of double placebo experiments rather than by semi-blind trials. In semi-blind trials, possible side effects induced by the placebo might not be sufficiently registered, and those induced by the verum cannot be adequately evaluated.